Poster Download: antibody development and quality control by mass spectometry

Download the poster

Please enable JavaScript in your browser to complete this form.

Lastname *

E-Mail *

Data protection *

• I accept the privacy policy.

Download results

Summary

• evitria productions show consistent glycan profiles between batches. These profiles are in agreement with commercially available (GMP) antibodies.
• Glycan analysis by LC-MS can verify glycan modifications, such as afucosylation, to provide further quality assurance.
• The production of high quality, reproducible material is critical for the development of antibody-based therapeutics. The evitria-Genovis workflow combines rapid, high quality, antibody production with high-throughput mass spectrometry for greater insight and control of key quality attributes.

Authors

• Desmond Schofield, evitria AG
• Christian Eberle, evitria AG
• Andreas Nägeli, Genovis AB
• Jonathan Sjögren, Genovis AB